4.6 Article

Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

Related references

Note: Only part of the references are listed.
Review Oncology

Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights

Christo Kole et al.

Summary: This article presents the latest advances in the treatment of pancreatic ductal adenocarcinoma (PDAC) using a combination of immunotherapy with other interventions such as chemotherapy and/or radiation. The role of the tumor microenvironment as a barrier to immunotherapy efficacy is outlined, and the use of immunotherapy biomarkers to detect response is examined.

CANCER MANAGEMENT AND RESEARCH (2022)

Review Cell Biology

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma

Tianyi Zhang et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with a high deposition of extracellular matrix (ECM) and poor prognosis. ECM proteins derived from tumor cells reduce the effectiveness of conventional cancer treatment and contribute to tumor progression and metastasis. Cancer-associated fibroblasts (CAFs) in the ECM are promising targets for novel anti-tumor interventions.

CELL DEATH & DISEASE (2022)

Article Oncology

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer A Randomized Clinical Trial

Thierry Conroy et al.

Summary: The 5-year results from the PRODIGE 24/Canadian Cancer Trials Group PA6 randomized clinical trial indicate that adjuvant treatment with modified FOLFIRINOX yields significantly longer survival than gemcitabine in patients with resected pancreatic ductal adenocarcinoma.

JAMA ONCOLOGY (2022)

Review Engineering, Biomedical

Regulation of tumor microenvironment for pancreatic cancer therapy

Xu Huang et al.

Summary: Pancreatic cancer is a deadly malignancy worldwide due to its insidious symptoms, early metastasis, and poor responses to treatment. Researchers are focusing on the tumor microenvironment as a key factor in treatment effectiveness and prognosis. Biomaterials are being developed to target components of the TME to inhibit cancer growth and metastasis.

BIOMATERIALS (2021)

Review Cell Biology

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth

Paul Manoukian et al.

Summary: Pancreatic tumors are characterized by abundant and highly desmoplastic stroma, with cancer-associated fibroblasts (CAFs) playing a crucial role in tumor development and architecture. However, the heterogeneity in CAF populations and the exact sources and functions of different CAF phenotypes remain to be fully understood. Understanding the roles of different subsets of CAFs within the stroma and the cellular dynamics that contribute to heterogeneity may be essential for developing novel therapies to improve clinical outcomes.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines

Laia Gorchs et al.

Summary: Despite advances in therapeutic modalities, the five-year overall survival for pancreatic cancer remains less than 10%, mainly due to the immunosuppressive effects of CAFs in the fibrotic stroma of pancreatic tumors. Current therapies fail to enhance the anti-tumor activity of T cells, but targeting CAFs may offer a new approach for the development of more effective combinational treatments.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Pathological Roles and Clinical Usefulness of Periostin in Type 2 Inflammation and Pulmonary Fibrosis

Junya Ono et al.

Summary: This article discusses the importance of Periostin as a biomarker in allergic diseases and pulmonary fibrosis, highlighting its correlation with disease severity, prognosis, and treatment response. It also summarizes recent developments in Periostin detection methods and describes factors influencing Periostin concentration under healthy conditions.

BIOMOLECULES (2021)

Article Oncology

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

Erin Helms et al.

Cancer Discovery (2020)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Immunology

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Daniel Ohlund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

Article Cell Biology

Sequential immunohistochemistry: a promising new tool for the pathology laboratory

Michiel van den Brand et al.

HISTOPATHOLOGY (2014)

Article Multidisciplinary Sciences

Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

Christine Feig et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Oncology

The Pancreas Cancer Microenvironment

Christine Feig et al.

CLINICAL CANCER RESEARCH (2012)

Review Medicine, Research & Experimental

Fibroblast Activation Protein in Remodeling Tissues

M. Jacob et al.

CURRENT MOLECULAR MEDICINE (2012)

Article Gastroenterology & Hepatology

Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance

Min Shi et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Oncology

Stromal myofibroblasts predict disease recurrence for colorectal cancer

Tadashi Tsujino et al.

CLINICAL CANCER RESEARCH (2007)

Review Biochemistry & Molecular Biology

PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma

A Östman

CYTOKINE & GROWTH FACTOR REVIEWS (2004)

Review Cell Biology

Myofibroblasts and mechano-regulation of connective tissue remodelling

JJ Tomasek et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)